Akuete Kwei, Guffey Danielle, Israelsen Ryan B, Broyles John M, Higgins Lori Jo, Green Todd D, Naimi David R, MacGinnitie Andrew J, Vitalpur Girish, Minard Charles G, Davis Carla M
Immunology, Allergy, and Rheumatology Section, Texas Children's Hospital, Houston, Texas; Department of Pediatrics, Baylor College of Medicine, Houston, Texas.
Dan L. Duncan Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, Texas.
Ann Allergy Asthma Immunol. 2017 Oct;119(4):339-348.e1. doi: 10.1016/j.anai.2017.07.028. Epub 2017 Sep 7.
Although previous single-center studies report the rate of anaphylaxis for oral food challenges (OFCs) as 9% to 11%, little is known regarding the epidemiology of clinical OFCs across multiple centers in the United States.
To examine the epidemiology, symptoms, and treatment of clinical low-risk OFCs in the nonresearch setting.
Data were obtained from 2008 to 2013 through a physician survey in 5 food allergy centers geographically distributed across the United States. Allergic reaction rates and the association of reaction rates with year, hospital, and demographics were determined using a linear mixed model. Meta-analysis was used to pool the proportion of reactions and anaphylaxis with inverse-variance weights using a random-effects model with exact confidence intervals (CIs).
A total of 6,377 OFCs were performed, and the pooled estimate of anaphylaxis was 2% (95% CI, 1%-3%). The rate of allergic reactions was 14% (95% CI, 13%-16%) and was consistent during the study period (P = .40). Reaction rates ranged from 13% to 33%. Males reacted 16% more frequently than females (95% CI, 4%-37.5%; P = .04). Foods challenged in 2013 varied geographically, with peanut as the most challenged food in the Northeast, Midwest, and West and egg as the most challenged in the South.
As the largest national survey of allergic reactions of clinical open OFCs in a nonresearch setting in the United States, this study found that performing clinical nonresearch open low-risk OFCs results in few allergic reactions, with 86% of challenges resulting in no reactions and 98% without anaphylaxis.
尽管先前的单中心研究报告口服食物激发试验(OFC)的过敏反应发生率为9%至11%,但对于美国多个中心临床OFC的流行病学情况知之甚少。
在非研究环境中研究临床低风险OFC的流行病学、症状及治疗。
通过对美国5个地理分布的食物过敏中心的医生进行调查,获取2008年至2013年的数据。使用线性混合模型确定过敏反应发生率以及反应发生率与年份、医院和人口统计学特征的关联。采用荟萃分析,使用具有精确置信区间(CI)的随机效应模型,以逆方差权重汇总反应和过敏反应的比例。
共进行了6377次OFC,过敏反应的合并估计发生率为2%(95%CI,1% - 3%)。过敏反应发生率为14%(95%CI,13% - 16%),在研究期间保持一致(P = 0.40)。反应发生率在13%至33%之间。男性的反应频率比女性高16%(95%CI,4% - 37.5%;P = 0.04)。2013年所检测的食物在地理上存在差异,花生是东北部、中西部和西部检测最多的食物,而鸡蛋是南部检测最多的食物。
作为美国非研究环境中临床开放性OFC过敏反应的最大规模全国性调查,本研究发现进行临床非研究开放性低风险OFC导致的过敏反应很少,86%的激发试验未引发反应,98%未发生过敏反应。